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Epidermal transient receptor potential vanilloid 1 in idiopathic small nerve ﬁbre disease,
diabetic neuropathy and healthy human subjects
Aims: The transient receptor potential vanilloid 1
(TRPV1) plays an important role in mediating pain
and heat. In painful neuropathies, intraepidermal
TRPV1 nerve ﬁbre expression is low or absent, sug-
gesting that pain generated is not directly related to
sensory nerve ﬁbres. Recent evidence suggests that
keratinocytes may act as thermal receptors via TRPV1.
The aim was to investigate epidermal TRPV1 expres-
sion in patients with neuropathic conditions associated
with pain.
Methods and results: In a prospective study of distal
small nerve ﬁbre neuropathy (DISN; n = 13) and dia-
betic neuropathy (DN; n = 12) intraepidermal nerve
ﬁbre density was assessed using the pan axonal mar-
ker PGP 9.5 and epidermal TPVR1 immunoreactivity
compared with controls (n = 9). Intraepidermal nerve
ﬁbres failed to show TRPV1 immunoreactivity across
all groups. There was moderate and strong TRPV1
reactivity of epidermal keratinocytes in 41.8% and 6%
for DISN, 32.9% and 2.9% for DN and 25.4% and 5.1%
for controls, respectively. Moderate keratinocyte
TRPV1 expression was signiﬁcantly increased in DISN
compared with controls (P = 0.01).
Conclusion: Our study suggests that in human painful
neuropathies, epidermal TRPV1 expression is mainly in
keratinocytes.
Keywords: diabetic neuropathy, epidermis, idiopathic small nerve ﬁbre disease, keratinocytes, neuropathic pain,
transient receptor potential vanilloid 1
Abbreviations: DISN, distal idiopathic small nerve ﬁbre disease; DN, diabetic neuropathy; DSFN, distal idiopathic
small nerve ﬁbre neuropathy; IENF, intraepidermal nerve ﬁbres; IENFD, intraepidermal nerve ﬁbre density; PBS,
phosphate-buffered saline; PGP, protein gene product; TRPV1, transient receptor potential vanilloid 1
Introduction
Capsaicin, the primary pungent compound in ‘hot’ chili
peppers, produces pain and inﬂammation when placed
on skin or mucous membranes. These responses are a
consequence of capsaicin activating the transient
receptor potential vanilloid 1 (TRPV1), a non-selective
cation channel receptor within C and A d nociceptors.
1
Several reports have demonstrated the existence of
TRPV1 in sensory neurons
2,3 and the cloning of rat
TRPV1 was a breakthrough in understanding its
properties and physiological functions.
4 TRPV1 has
now been found to be widely distributed amongst
different types of tissues and has been identiﬁed in the
human brain,
5 kidney,
6 bronchial epithelial cells
7 and
recently in human keratinocytes in the epidermis.
8
TRPV1, by its activation through noxious temperature,
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ingly recognized role in the biology of dermatological
and neuropathic conditions,
8 with anatomical distri-
bution and disease inﬂuencing expression. TRPV1
expression in keratinocytes has recently led researchers
to propose that keratinocytes may act as thermal
receptors.
9 TRPV1 has been shown to be essential for
the modalities of pain sensation and thermal hyper-
algia.
10 However, its role in the pathogenesis of
neuropathic pain, such as occurs in peripheral neuro-
pathies, remains controversial. Although one study in
a patient with postherpetic neuralgia has shown
increased TRPV1+ intraepidermal nerve ﬁbres (IENF),
a recent study in patients with painful neuropathy
found that TRPV1+ IENF were reduced and sometimes
completely absent, suggesting that TRPV1 in epidermal
axons is not primarily involved in the pathogenesis of
neuropathic pain.
11 Rather, it has been suggested that
the skin as a whole may act as a polymodal nociceptor
which undergoes functional changes in painful condi-
tions.
11 We set out to study the expression of epidermal
TRPV1 in human skin by investigating two different
types of neuropathy compared with healthy controls.
Idiopathic small nerve ﬁbre neuropathy was chosen
because spontaneous heat pain is one of its primary
characteristics, diabetic neuropathy (DN) because this
is a common cause of sensory neuropathy.
Materials and methods
In a prospective study, hypothenar intraepidermal
nerve ﬁbre density (IENFD) from healthy subjects and
from subjects referred for investigation of neuropathy
was assessed.
12 In the subgroup reported here, the
distribution of TPVR1 in the epidermis of the human
skin is described. We studied the different epidermal
TPVR1 staining intensity and distribution of patients
with length-dependant DN and distal idiopathic small
nerve ﬁbre neuropathy (DSFN) and compared these
with healthy subjects.
subjects
After informed consent, those patients were included
who had length-dependent DN with glove and stocking
sensory symptoms (hypoaesthesia and ⁄ or dysaesthe-
sia) with reduced touch perception to cotton wool and
vibration sensation (128 Hz tuning fork) occurring in
the presence of diabetes and who were without patho-
logical levels of vitamin B12, thyroid-stimulating
hormone and T4. Patients with sensory symptoms,
but normal sensory testing to superﬁcial touch and
vibration were excluded.
Distal idiopathic small nerve ﬁbre disease (DISN) was
diagnosed in the presence of paraesthesiae (abnormal
sensory perception) with additional ﬁndings of distal
predominant small nerve ﬁbre dysfunction (increased
thermal and pin-prick sensation) on neurological
examination.
13 On sensory testing the paraesthesiae
are typically painful. Sensory symptoms had to occur
without neurophysiological and clinical evidence of
large nerve ﬁbre disease (normal ulnar and median
nerve sensory motor nerve conduction, normal sural
nerve conduction and normal peroneal motor nerve
conduction and normal monoﬁlament testing (200 mg)
for all ﬁve digit tips bilaterally. Detailed history and
tests excluded diabetes mellitus, amyloidosis, toxic sub-
stances (alcohol, lead) and inherited sensory and auto-
nomic neuropathies.
Healthy subjects were recruited from hospital staff
and students from the National University of Singapore.
One neurologist (E.P.W.-S.) examined all healthy sub-
jects to exclude neuropathy based on the absence of
clinical features of sensory and motor symptoms and
a normal sensory motor examination. Inclusion was
furthermore dependent upon a negative history for
diabetes, alcoholism, radiculopathies, ulnar or median
nerve entrapments and no previous exposure to chemo-
therapy or other neurotoxic medications. Subjects
<21 years old, with hand sepsis or ulceration were
excluded.
Procedures
All subjects gave informed consent and the National
University Hospital Institutional Review Board appro-
ved the study. Hospital ethical guidelines are in
accordance with the 1964 Declaration of Helsinki.
skin biopsy specimens
Skin biopsy specimens were taken from the hypothenar
region of the non-dominant hand using a 3-mm punch
after local inﬁltration with 2% lignocaine, as previously
described.
12 Quantiﬁcation of epidermal TRPV1 expres-
sion was performed using computerized image analysis
(Image-Pro
  Plus software; Media Cybernetics
 , Silver
Spring, MD, USA) linked to an upright microscope
(Olympus
  BX60, DP70 digital camera). The whole of
the epidermis including basal and suprabasal areas was
evaluated.
immunocytochemistry
The skin biopsy specimens were cryoprotected by
immersion in 15% sucrose and sectioned at 30 lm
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glass slides, washed in ﬁve to six 1-h changes of
phosphate-buffered saline (PBS) and incubated for 1 h
in a solution of serum (Vector, Burlingame, CA, USA)
to block non-speciﬁc binding of the antibody. This was
followed by incubation overnight in afﬁnity-puriﬁed
rabbit polyclonal antibodies to neuropeptide protein
gene product (PGP) 9.5 or TRPV1. PGP 9.5 is found in
vertebrate neurons and neuroendocrine cells and is
commonly used to detect intraepidermal nerve ﬁbres.
14
The antibody to TRPV1 was purchased from Afﬁnity
Bioreagents (Golden, CO, USA). The sections were
rinsed with PBS and incubated for 1 h at room
temperature in a 1:200 dilution of biotinylated goat
antirabbit IgG (Vector), followed by three changes of
PBS to remove non-reacting secondary antibody. The
sections were then reacted for 1 h at room temperature
with an avidin-biotinylated horseradish peroxidase
complex. The bound antibodies were visualized by
treatment for 5 min in 0.05% 3,3,diaminobenzidine
tetrahydrochloride and 0.2% nickel ammonium sul-
phate in Tris buffer with 0.05% hydrogen peroxide. The
colour reaction was stopped with several washes of Tris
buffer, followed by PBS. Sections were mounted on
gelatin-coated glass slides, dehydrated and lightly
counterstained with methyl green before cover-slip-
ping. Control experiments replaced the primary anti-
body with PBS or non-immune rabbit IgG serum
fraction. The experiments were performed on the skin
of the hypothenar region and showed lack of immuno-
reactivity.
intraepidermal nerve fibre density
assessment
IENFD assessment was achieved by staining skin
obtained from the hypothenar region with PGP 9.5,
as previously described.
12
quantification of trpv1 receptor staining in
keratinocytes
Assessment of immunoreactivity with TRPV1 was
performed using a previously described and standard-
ized semiquantitative assessment of photographs taken
from antibody-labelled sections.
15 Using Image-Pro
 
Plus software, the colour image was converted into a
black-and-white image with eight levels of mono-
chrome grey tones (Figure 1). This picture was termed
the ‘ﬁlter’. The operator then selected the cut-off level
of the perceived limit of TRPV1 staining. The operator
was aided in this selection by a diagrammatic scale of
the range of staining intensities seen in the ‘ﬁlter’. The
software program arbitrarily attaches a number rang-
ing from 0 to 225 across all intensities of immunore-
activity, with absent (visually perceived as white)
reactivity being ranked 225. The chosen numerical
values used to assign intensity of reactivity with the
Image-Pro
  Plus software were 155–225 for absent
staining (equivalent to immunonegativity); 154–124
for moderate and 123–0 for the highest level of
A
C
B
Figure 1. A, standard skin transient receptor potential vanilloid 1
(TRPV1) immunoreactivity in a patient with distal idiopathic small
nerve ﬁbre disease. B, the same image converted to black and white
with eight levels of monochrome grey tones. C, the same image
further converted into colour coding: green represents the most
intense immunoreactivity, yellow moderate reactivity and red
immunonegativity. (TRPV1 peroxidase stain.)
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selected by the operator at levels thought to represent
moderate and intense immunoreactivity of cells. The
155–225 range (equivalent to immunonegativity) was
assigned a red colour, 154–124 (moderate reactivity)
yellow and 123–0 (highest immunoreactivity) green
(Figure 1). The Image-Pro
  Plus software was then
used to calculate the areas of the different intensities of
TRPV1 reativity of the epidermal tissue. The data were
formulated as the percentage of epidermal tissue with-
out and with moderate and strong immunoreactivity
for TRPV1. Measurements were performed for ﬁve ﬁelds
per patient chosen at random from two sections
oriented longitudinally (425 lm). The operator delin-
eated the ﬁeld of epidermal skin to be assessed by the
software (Figure 1). The percentage area of TRPV1
keratinocyte immunoreactivity was then automatically
derived for the whole epidermal region as well as
separately for the suprabasal and basal compartments.
This subdivision was designed to assess separately the
more actively dividing basal cell layers from the more
differentiated keratinocyte cells located higher in the
epidermis.
16 The suprabasal epidermal compartment
was taken as the top 2 ⁄ 3 region in the absence of
anchoring papillae extending into the dermis. For
anchoring papillae two cell layers superior to the basal
laminae were included. The mean suprabasal and basal
epidermal regions of absent, moderate and intense
TRPV1 reactivity were obtained for each subject and
subsequently summarized as means for each of the
three groups.
The following photographic conditions applied: sen-
sitivity ISO200, exposure time 1 ⁄ 18 s, objective
enlargement ·40, exposure mode manual and spot
30%, photo size 4080 · 3072 lm.
analysis
One-way anova was used to calculate differences in
intensity of reactivity between the three groups for the
epidermis as a whole and subdivided into suprabasal
and basal compartments. P < 0.05 was considered to
be signiﬁcant.
Results
We examined 13 patients (nine female; mean age
49 ± 13.5 years, range 22–65) with DISN, 12 patients
(four female; mean age 51 ± 17.3 years, range 24–73)
with DN and nine healthy subjects (six female; mean
age 45 ± 11.9 years, range 22–61).
clinical data
The mean blood sugar level of the diabetic patients was
9.5% (range 5.9–13.8%). In our laboratory, non-
diabetic levels are <6.4%, optimal diabetic control is
6.5–7.0% and poor diabetic control is >8.0%. Six of the
patients with idiopathic small nerve ﬁbre disease and
three of those with diabetes complained of a spontane-
ous or intermittent burning sensation in the hands or
feet at the time of the biopsy. It was not possible to
estimate accurately the length of time the burning
sensation had been present.
pgp 9.5 staining for axons
Normal numbers of epidermal nerves were observed in
control patients, and signiﬁcantly (P < 0.05) fewer
nerve ﬁbres were seen in idiopathic small nerve ﬁbre
disease and DN (Table 1).
trpv1 immunohistochemistry
The epidermis showed heterogeneous immunoreactiv-
ity, with increased reactivity occurring more in kerat-
inocytes of the suprabasal layer of the epidermis
(Figure 2). Tables 1–3 show the intensity of reactivity
of the three different clinical groups according to
analysis of the whole epidermal region and subdivision
Table 1. Mean percentage
and degree of TRPV1
expression for cells within
the epidermis
Groups n IENFD
Mean % absent
TRPV1 expression
Mean % moderate
TRPV1 expression
Mean % strong
TRPV1 expression
DISN 13 1.5 (±1.8) 52.2 (±19.9) 41.8 (14.3)* 6 (7.5)
DN 12 0.8 (±1.1) 64.2 (±16.6) 32.9 (13) 2.9 (4.3)
Controls 9 2.6 (±2.2) 69.5 (±20.6) 25.4 (17.4) 5.1 (5.7)
DISN, distal small nerve ﬁber disease; DN, diabetic neuropathy; IENFD, intraepidermal nerve
ﬁbre density.
The numbers in bracket represent the standard deviation.
*Indicates a signiﬁcant difference of P = 0.015 between small nerve ﬁbre and healthy groups.
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statistically signiﬁcant increase in TRPV1 immuno-
reactivity was observed in keratinocytes of patients with
idiopathic small nerve ﬁbre disease. TRPV1 expression
was signiﬁcantly increased in the whole epidermal
region in DISN when compared with controls (P =
0.01). Further analysis showed that the suprabasal
areas were consistently more immunoreactive than
basal regions. Keratinocyte reactivity (moderate) for
TRPV1 in the suprabasal region was signiﬁcantly
increased (P = 0.005) in DISN compared with healthy
groups, but failed to reach signiﬁcance for the diabetic
group and when extending analysis to the basal region.
Keratinocyte reactivity was mostly cytoplasmic, with
little or no reactivity of the nucleus (Figure 2).
Discussion
This study reports on the epidermal distribution of
TRPV1 in the glabrous hand skin from healthy
controls, patients with DISN and DN. The most impor-
tant ﬁnding was the increased keratinocyte immuno-
reactivity to TRPV1 in patients with DISN in the
absence of IENF immunoreactivity with TRPV1. For
many years it was thought that TRPV1 was expressed
primarily in peripheral sensory neurons.
17 Studies
performed both in the skin of humans and rodents
have carefully investigated the distribution of TRPV
receptors in nerve tissue and across different tissues.
8,18
Stander’s study investigating the distribution of TRPV1
in cutaneous sensory nerves of human skin pointed out
that in healthy humans, IENF do not or only poorly
immunoreact with TRPV1.
8 Skin areas with strong
TRPV1 reactivity were the dermal sensory axons, hair
follicles, blood vessels and keratinocytes. In contrast, a
recent study has found TRPV1 expression throughout
the peripheral nervous system, including intraepider-
mal ﬁbres.
11 The IENF immunonegativity in both our
study and that of Stander et al. may be due to
differences in antibody speciﬁcity. Although lower
speciﬁcity of the TRPV1 antibodies used in our study
and that of Stander et al. may have played a role, this
seems a moot point considering Lauria’s recent study
Keratin
Dermis
Melanocytes
Figure 2. Maximal transient receptor potential vanilloid 1 (TRPV1)
immunoreactivity is seen in the keratinocytes of the suprabasal layer
of the epidermis. The parentheses indicate the suprabasal region.
Note the lack of nuclear TRPV1 staining. (TRPV1 peroxidase stain.)
Table 2. Mean percentage
of TRPV1 expression for
cells within the suprabasal
epidermal regions
Groups n
Mean % absent
TRPV1 expression
Mean % moderate
TRPV1 expression
Mean % strong
TRPV1 expression
DISN 13 44.6 (±22.4) 48.1 (15.9)* 7.3 (9.2)
DN 12 66.7 (±19.1) 39.5 (14.3) 3.8 (6)
Controls 9 66.9 (±22.7) 27.3 (17.9) 5.8 (6.4)
*A signiﬁcant difference of P = 0.005 between small nerve ﬁbre and healthy groups.
DISN, distal small nerve ﬁbre disease; DN, diabetic neuropathy.
Table 3. Mean percentage
of TRPV1 expression for
cells within the basal
epidermal regions
Groups n
Mean % absent
TRPV1 expression
Mean % moderate
TRPV1 expression
Mean % heavy
TRPV1 expression
DISN 13 73.4 (±13.9) 24.3 (11.6) 2.3 (2.8)
DN 12 82.3 (±14.2) 16.9 (13.1) 0.8 (1.2)
Controls 9 80.2 (±17.2) 17.3 (14.9) 2.5 (3.3)
DISN, distal small nerve ﬁbre disease; DN, diabetic neuropathy.
678 E P Wilder-Smith et al.
  2007 The Authors. Journal compilation   2007 Blackwell Publishing Ltd, Histopathology, 51, 674–680.showing reduced or absent TRPV1 IENF density in the
epidermis of patients with neuropathic pain.
11
The ﬁnding of this study that keratinocyte TRPV1 is
signiﬁcantly increased in patients with DISN suggests
that one of the primary characteristics of DISN–
spontaneous heat pain – may be related to increased
keratinocyte TRPV1. The robust evidence of strong
TRPV1 expression in keratinocytes
9 has led to the
belief that keratinocytes are capable of functioning as
one of the main thermosensory receptors.
19 Studies
using cultured human epidermal keratinocytes have
conﬁrmed that expressed TRPV1 responds to heat
and noxious stimuli
20 and that activation of epider-
mal keratinocyte TRPV1 results directly in release
of cyclooxygenase-2, one of the main mediators of
inﬂammation.
21
The ﬁnding of reduced IENFD in our patients with
DISN further supports the notion that the IENF
themselves do not play a primary role in the production
of heat sensation. To our knowledge, only one study
has demonstrated increased TRPV1 immunoreactivity
in a patient with painful neuropathy (postherpetic
neuralgia).
22 It is interesting to note that although the
authors report a somewhat patchy increase of IENF
with increased TRPV1, the immunoﬂuorescence also
seems clearly to show increased keratinocyte expres-
sion in the skin afﬂicted with neuropathy. The authors
propose that pain is maintained by a peripheral
nociceptive maladaptation located within the skin, a
theory apparently supported by neuropathic pain
directly and drastically responding to excision of the
painful skin.
The association of increased keratinocyte TRPV1 in
human conditions with pain has recently been dem-
onstrated in women with breast pain, in patients with
rectal hypersensitivity and faecal urgency, as well as in
pruritic skin of patients with prurigo nodularis.
8,23,24
We recently described a patient with steroid-responsive
small nerve ﬁbre symptoms of burning feet and hands,
where keratinocytes showed strong TRPV1 expres-
sion.
25 On follow-up skin biopsy after steroid adminis-
tration, keratinocyte TRPV1 expression was drastically
reduced in parallel with remission of clinical symptoms
(manuscript in preparation).
The semiquantitative technique employed in this
study has shown that in the epidermis of the healthy
human glabrous skin about one-third of the keratino-
cytes show moderate TRPV1 expression, around 5%
intensely so. The suprabasal epidermal area showed
highest expression across all three groups, suggesting
that expression may be linked to greater differentiation
of keratinocytes, which is least in the basal epidermal
region.
16 This contrasts with the study by Stander
et al., which found the highest expression in the basal
keratinocytes.
8 This may be due to differences in
TRPV1 antibody speciﬁcity, in addition to the different
skin type (glabrous) examined in the present study.
Our study has several shortcomings. Because of
small numbers, it was not possible to perform statistical
analysis to analyse the effect of burning compared with
no burning across the groups or within groups. This
would be of considerable interest in future studies.
Furthermore, neuropathic pain or thermal hypersensi-
tivity was also seen in some of the patients with DN.
This overlap of clinical symptoms may help to explain
why the mean keratinocyte TRPV1 expression in the
DN group was also higher compared with controls.
In conclusion, our data show that increased kera-
tinocyte TRPV1 expression in patients with small nerve
ﬁbre neuropathy and, to a lesser extent, in DN may
play a role in explaining some of the typical clinical
features of increased sensitivity to noxious stimuli.
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